01 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/licensing-partner-of-shenzhen-chipscreen-biosciences---huyabio-international-receives-regulatory-approval-for-chidamide-monotherapy-of-peripheral-t-cell-lymphomaptcl-in-japan-301435093.html
LOOKING FOR A SUPPLIER?